Google Backs Biomass Fuel Firm CoolPlanetBiofuels

The venture capital arm of Google has invested in a start-up that is developing technology to produce fuel from inedible biomass such as grass and wood chips.

The process, deployed by CoolPlanetBiofuels, also produces a byproduct that can capture carbon and also be added to soil to improve crop yields, leading to what Google Ventures described as a "negative carbon fuel."

"While we have made significant progress over the past couple of years, this new infusion of capital, coupled with the expertise of the Google Ventures team, enables our team to scale even faster," Mike Cheiky, chief executive of Camarillo, Calif.-based CoolPlanet, said in a statement on Thursday.

Google's undisclosed amount of Series B funding follows a $42 million investment last month by Google and Silicon Valley venture capitalist Vinod Khosla in a weather insurance start-up.

Also last month, Google Ventures invested in power-saving energy conversion technology firm Transphorm.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.